SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Julius Caesar Synthetic CCD

PatientJulius Caesar
Date of birth1972-07-12
IdentifiersMRN HR-AC001-SYN; SSN (made up) 000-01-6022
Document date2026-11-01
AuthorLucius Fairbanks-Okonkwo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Urgent visit after a witnessed collapse with jerking and confusion, the third spell in eighteen months: history, examination, ECG, tests, cardiac monitor, seizure safety, and neurology referral. Concerns: Six days ago he collapsed at a long outdoor ceremony after a strange rising feeling, with jerking of both arms, a bitten tongue, and twenty minutes of confusion; it is his third spell in eighteen months, and he wants to know why he collapses and whether it will happen again in public; He wants to keep working, travelling, speaking, and riding; He is frustrated at being told not to drive. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Lisinopril 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth each morningOral route2026-08-04activeS
Levetiracetam 500 mg oral tablet, one tablet by mouth twice daily500 mg twice daily, morning and eveningOral route2026-08-18activeS
Atorvastatin 80 mg oral tablet, one tablet by mouth at bedtimeOne tablet by mouth at bedtimeOral route2026-08-18activeS
Aspirin 81 mg delayed-release tablet, one tablet by mouth dailyOne tablet by mouth daily with foodOral route2026-08-18activeS
Acetaminophen 500 mg oral tablet, one or two tablets by mouth every 6 hours as needed for fever or sore throat (no more than 3 g a day)One or two tablets every 6 hours as needed, at most 3 g a day, for up to a weekOral route2026-09-08 to 2026-09-14completedS
Amlodipine 5 mg oral tablet, one tablet by mouth dailyOne tablet by mouth each morningOral route2026-09-15activeS

Procedures

ProcedureDatesStatusEvidence
12-lead ECG: sinus rhythm at 70 per minute, PR 168 ms, QRS 92 ms, QTc 412 ms, voltage criteria for left ventricular hypertrophy; no pre-excitation, Brugada pattern, or heart block2026-08-04 to 2026-08-04completedS
14-day ambulatory ECG patch, fitted the day after the first visit: sinus rhythm throughout, no atrial fibrillation or flutter, no pause longer than 2 seconds, no high-grade block; one patient-triggered event (light-headed on standing) in sinus rhythm2026-08-05 to 2026-08-18completedS
Routine EEG with sleep: intermittent left temporal sharp waves in drowsiness and light sleep; normal background; no seizure recorded2026-08-11 to 2026-08-11completedS
MRI of the brain with diffusion-weighted, susceptibility-weighted, and epilepsy-protocol sequences: no acute infarct; a chronic 1.5 cm cortical and subcortical infarct with gliosis in the left posterior temporal lobe; moderate periventricular and deep white matter hyperintensities (Fazekas grade 2); no microbleeds, mass, vascular malformation, cyst, or calcified lesion; hippocampi normal2026-08-12 to 2026-08-12completedS
CT angiography of the head and neck: calcified plaque at the left carotid bifurcation with less than 30 percent stenosis; no other extracranial or intracranial stenosis, dissection, aneurysm, or arteriovenous malformation2026-08-12 to 2026-08-12completedS
Transthoracic echocardiogram with agitated saline: ejection fraction 60 percent, mild concentric left ventricular hypertrophy, normal left atrial size, no thrombus or valve disease; no shunt2026-08-13 to 2026-08-13completedS
Second ambulatory ECG monitor for four more weeks (more than 40 days of monitoring in all): sinus rhythm throughout; no atrial fibrillation or flutter; rare isolated ectopic beats2026-08-18 to 2026-09-14completedS
Home sleep apnea test: apnea-hypopnea index 4 per hour, oxygen saturation nadir 91 percent; no sleep apnea2026-09-10 to 2026-09-10completedS
Advance care planning conversation, about 20 minutes2026-10-06 to 2026-10-06completedS

Immunizations

DateVaccineStatusEvidence
2019-04-10Tetanus, diphtheria, and pertussis (Tdap) boostercompletedS
2026-10-06Influenza vaccine, 2026-2027 seasoncompletedS
2026-10-06Recombinant zoster vaccine, dose 1 of 2completedS
2026-10-06Pneumococcal conjugate vaccine (PCV20), single dosecompletedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
about 82 to 81 BCA severe quartan fever (a fever every fourth day) while in hiding as a young manD (CLM-0004)
date not recordedPlutarch: 'distemper in the head' and 'epileptic fits', the first at Corduba in Spain; the date is not recordedD (CLM-0005)
his last years; no dates recordedSuetonius: sudden fainting fits and nightmares towards the end of his life, and two attacks of the 'falling sickness' (comitialis morbus) on campaignD (CLM-0006)
6 April 46 BC in the old Roman calendar (about 7 February 46 BC, Julian)By one account in Plutarch, his 'usual sickness' seized him at the battle of Thapsus and he was carried to a towerD (CLM-0007)
retrospective interpretationThe nature of the attacks is disputed: epilepsy, transient ischemic attacks, and other causes have all been proposedR (CLM-0013, CLM-0014, CLM-0015)

Family History

RelativeConditionAge at deathEvidence
fatherDied suddenly in the morning, without apparent cause, while putting on his shoes, when his son was fifteen; cause not recorded in the cited sourceD (CLM-0002, CLM-0003)
natural daughterDied in childbirth as a young womanD (CLM-0010)

Health Concerns

ConcernStatusEvidence
Six days ago he collapsed at a long outdoor ceremony after a strange rising feeling, with jerking of both arms, a bitten tongue, and twenty minutes of confusion; it is his third spell in eighteen months, and he wants to know why he collapses and whether it will happen again in publicactiveS
He wants to keep working, travelling, speaking, and ridingactiveS
He is frustrated at being told not to driveactiveS

Assessment

Most recent measures: Hemoglobin [Mass/volume] in Blood 14.8 on 2026-08-04; Leukocytes [#/volume] in Blood by Automated count 6.9 on 2026-08-04; Platelets [#/volume] in Blood by Automated count 232 on 2026-08-04; Sodium [Moles/volume] in Serum or Plasma 140 on 2026-08-18; Potassium [Moles/volume] in Serum or Plasma 4.5 on 2026-08-18; Creatinine [Mass/volume] in Serum or Plasma 1.02 on 2026-08-18; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 86 on 2026-08-18; Glucose [Mass/volume] in Serum or Plasma 96 on 2026-08-04; Calcium [Mass/volume] in Serum or Plasma 9.4 on 2026-08-04; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 34 on 2026-10-27; Hemoglobin A1c/Hemoglobin.total in Blood 5.6 on 2026-08-04; Thyrotropin [Units/volume] in Serum or Plasma 1.8 on 2026-08-04; Cholesterol [Mass/volume] in Serum or Plasma 136 on 2026-10-27; Cholesterol in HDL [Mass/volume] in Serum or Plasma 46 on 2026-10-27; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 68 on 2026-10-27; Triglyceride [Mass/volume] in Serum or Plasma 110 on 2026-10-27; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 on 2026-10-27; Total score [AUDIT-C] 1 on 2026-10-06; Total score [MoCA] 28 on 2026-09-15; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 2026-10-06 [S]

Strengths and supports: engagement in care [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Recurrent transient episodes of collapse: six days ago a witnessed collapse with stiffening and jerking of both arms for about a minute, a bitten tongue, and about twenty minutes of confusion, after a rising strange feeling and dizziness; two briefer spells of staring and unresponsiveness in the past eighteen months; cause not yet known (seizure, convulsive syncope, or transient ischemic attack)resolvedconfirmed R56.9S — Synthetic presenting problem anchored to the documented accounts of falling attacks and fainting fits; it resolves when the cause is found.
Hypertension, stage 2: 152/94 and 148/92 mmHg today; told of high blood pressure about three years ago and never treatedactiveconfirmed I10S — Synthetic vascular risk factor; no blood pressure from his lifetime is known.
Hyperlipidemia: LDL 158 mg/dL, triglycerides 170 mg/dL, HDL 44 mg/dLactiveconfirmed E78.5S — Synthetic vascular risk factor; no lipid value from his lifetime is known.
Focal epilepsy with a structural vascular cause: focal impaired-awareness seizures with automatisms, one evolving to a bilateral tonic-clonic seizure, arising from a chronic left temporal cortical infarct, with left temporal sharp waves on EEGactiveconfirmed G40.209S — Synthetic modern diagnosis anchored to the documented falling attacks; the ILAE 2017 seizure types and a structural cause are chosen for teaching and make no claim about what he had.
Chronic left posterior temporal cortical infarct, not recognized before the seizures, with moderate small-vessel white matter disease and a non-stenotic left carotid plaque; no residual deficitactiveconfirmed I69.398S — Synthetic modern finding anchored to the retrospective cerebrovascular hypothesis; it makes no claim about his real brain.
Acute viral upper respiratory infection with low-grade fever and poor sleep, three weeks after starting levetiracetam; rapid COVID-19 and influenza tests negative; resolvedresolvedconfirmed J06.9S — Synthetic intercurrent illness, chosen to teach cold-remedy choices with hypertension, aspirin, and an antiseizure medicine, and sleep loss as a seizure trigger; it echoes no documented illness.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-08-04Hemoglobin [Mass/volume] in Blood14.8g/dL13.2-16.6 g/dLNormalS
2026-08-04Leukocytes [#/volume] in Blood by Automated count6.910*3/uL4-11 10*3/uLNormalS
2026-08-04Platelets [#/volume] in Blood by Automated count23210*3/uL150-400 10*3/uLNormalS
2026-08-04Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-08-04Potassium [Moles/volume] in Serum or Plasma4.2mmol/L3.5-5.1 mmol/LNormalS
2026-08-04Creatinine [Mass/volume] in Serum or Plasma0.98mg/dL0.74-1.35 mg/dLNormalS
2026-08-04Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M91mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-08-04Glucose [Mass/volume] in Serum or Plasma96mg/dL70-99 mg/dLNormalS
2026-08-04Calcium [Mass/volume] in Serum or Plasma9.4mg/dL8.6-10.3 mg/dLNormalS
2026-08-04Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma28U/L7-56 U/LNormalS
2026-08-04Hemoglobin A1c/Hemoglobin.total in Blood5.6%<=5.6%NormalS
2026-08-04Thyrotropin [Units/volume] in Serum or Plasma1.8m[IU]/L0.4-4.5 mIU/LNormalS
2026-08-04Cholesterol [Mass/volume] in Serum or Plasma236mg/dL<=200 mg/dLHighS
2026-08-04Cholesterol in HDL [Mass/volume] in Serum or Plasma44mg/dL>=40 mg/dLNormalS
2026-08-04Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation158mg/dL<=129 mg/dLHighS
2026-08-04Triglyceride [Mass/volume] in Serum or Plasma170mg/dL<=149 mg/dLHighS
2026-08-04Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S
2026-08-04Total score [AUDIT-C]1{score}S
2026-08-18Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
2026-08-18Potassium [Moles/volume] in Serum or Plasma4.5mmol/L3.5-5.1 mmol/LNormalS
2026-08-18Creatinine [Mass/volume] in Serum or Plasma1.02mg/dL0.74-1.35 mg/dLNormalS
2026-08-18Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M86mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-09-15Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
2026-09-15Total score [MoCA]28{score}S
2026-10-27Cholesterol [Mass/volume] in Serum or Plasma136mg/dL<=200 mg/dLNormalS
2026-10-27Cholesterol in HDL [Mass/volume] in Serum or Plasma46mg/dL>=40 mg/dLNormalS
2026-10-27Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation68mg/dL<=129 mg/dLNormalS
2026-10-27Triglyceride [Mass/volume] in Serum or Plasma110mg/dL<=149 mg/dLNormalS
2026-10-27Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma34U/L7-56 U/LNormalS
2026-10-27Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S
2026-10-06Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
2026-10-06Total score [AUDIT-C]1{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-08-04Body height182cmS
2026-08-04Body weight76kgS
2026-08-04Body mass index (BMI) [Ratio]22.9kg/m2S
2026-08-04Systolic blood pressure152mm[Hg]S
2026-08-04Diastolic blood pressure94mm[Hg]S
2026-08-04Heart rate70/minS
2026-08-04Respiratory rate14/minS
2026-08-04Body temperature36.7CelS
2026-08-04Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-08-18Body height182cmS
2026-08-18Body weight75.8kgS
2026-08-18Body mass index (BMI) [Ratio]22.9kg/m2S
2026-08-18Systolic blood pressure140mm[Hg]S
2026-08-18Diastolic blood pressure88mm[Hg]S
2026-08-18Heart rate68/minS
2026-08-18Respiratory rate14/minS
2026-08-18Body temperature36.6CelS
2026-08-18Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-09-08Body height182cmS
2026-09-08Body weight75.4kgS
2026-09-08Body mass index (BMI) [Ratio]22.8kg/m2S
2026-09-08Systolic blood pressure136mm[Hg]S
2026-09-08Diastolic blood pressure86mm[Hg]S
2026-09-08Heart rate84/minS
2026-09-08Respiratory rate16/minS
2026-09-08Body temperature37.8CelS
2026-09-08Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-09-15Body height182cmS
2026-09-15Body weight75.6kgS
2026-09-15Body mass index (BMI) [Ratio]22.8kg/m2S
2026-09-15Systolic blood pressure136mm[Hg]S
2026-09-15Diastolic blood pressure84mm[Hg]S
2026-09-15Heart rate68/minS
2026-09-15Respiratory rate14/minS
2026-09-15Body temperature36.6CelS
2026-09-15Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-10-06Body height182cmS
2026-10-06Body weight75.2kgS
2026-10-06Body mass index (BMI) [Ratio]22.7kg/m2S
2026-10-06Systolic blood pressure128mm[Hg]S
2026-10-06Diastolic blood pressure80mm[Hg]S
2026-10-06Heart rate66/minS
2026-10-06Respiratory rate14/minS
2026-10-06Body temperature36.6CelS
2026-10-06Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-10-27Body height182cmS
2026-10-27Body weight75kgS
2026-10-27Body mass index (BMI) [Ratio]22.6kg/m2S
2026-10-27Systolic blood pressure124mm[Hg]S
2026-10-27Diastolic blood pressure76mm[Hg]S
2026-10-27Heart rate66/minS
2026-10-27Respiratory rate14/minS
2026-10-27Body temperature36.6CelS
2026-10-27Oxygen saturation in Arterial blood by Pulse oximetry98%S

Encounters

DatePurposeStatusProvenance
2026-08-04Urgent visit after a witnessed collapse with jerking and confusion, the third spell in eighteen months: history, examination, ECG, tests, cardiac monitor, seizure safety, and neurology referralfinishedS
2026-08-18Two-week follow-up with the neurology consultation: EEG, MRI, vascular imaging, echocardiogram, and monitor reviewed; diagnosis made and treatment startedfinishedS
2026-09-08Same-day sick visit for a cold with low feverfinishedS
2026-09-15Four-week review of levetiracetam, blood pressure, the second rhythm monitor, mood, and cognitionfinishedS
2026-10-06Adult preventive visitfinishedS
2026-10-27Ten-week review: seizure control, lipids on atorvastatin, blood pressure, and driving and safetyfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Work-up of transient loss of consciousness: witness account, orthostatic vital signs, 12-lead ECG today, a 14-day ambulatory ECG patch from tomorrow, blood count, electrolytes, calcium, glucose, kidney and liver tests, HbA1c, lipids, and TSH; EEG and MRI of the brain with diffusion-weighted and epilepsy-protocol sequences; CT angiography of the head and neck; transthoracic echocardiogramcompletedGL-AAN-FIRSTSZ-2015, GL-ACC-SYNC-2017, GL-AHA-SSP-2021S
Neurology consultation: is this epilepsy, syncope, or transient ischemic attack; review of the EEG, MRI, and vascular imaging; whether to start an antiseizure medicine and which; stroke prevention; and drivingcompletedGL-AAN-FIRSTSZ-2015, GL-ILAE-SZ-2017S
Seizure safety from today: no driving until a seizure-free period set by state law and his neurologist; showers rather than baths; no swimming or riding alone; no climbing to heights; regular sleep of at least seven hours; a written seizure action plan for his staff, including when to call emergency servicescompletedGL-AAN-FIRSTSZ-2015S
Blood pressure: lisinopril 10 mg daily from today; home blood pressure log twice daily; potassium and creatinine in two weeks; target below 130/80 mmHgcompletedGL-AHA-HTN-2025, GL-CMID-2026S
Antiseizure medicine: levetiracetam 500 mg twice daily, with teaching about irritability, low mood, and drowsiness; a seizure diary; no missed dosescompletedGL-AAN-NEWASM-2018, GL-AAN-FIRSTSZ-2015S
Secondary stroke prevention for the cortical infarct: aspirin 81 mg daily, atorvastatin 80 mg at bedtime with a lipid panel at 4 to 12 weeks (LDL target below 70 mg/dL), blood pressure below 130/80 mmHg with a second drug if needed, a home sleep apnea test, and a further four weeks of ambulatory rhythm monitoring (more than 30 days in all) for occult atrial fibrillationcompletedGL-AHA-SSP-2021, GL-AHA-SILENT-2017, GL-CMID-2026S
Lifestyle: Mediterranean-style diet with sodium below 2.3 g a day; aerobic activity at least 150 minutes a week; alcohol kept at his present low level; no tobaccocompletedGL-AHA-SSP-2021, GL-CMID-2026S
Mood and cognition after the diagnosis: PHQ-9 four weeks after starting levetiracetam and then periodically; MoCA in the first months after the infarct was foundcompletedGL-CMID-2026, GL-AHA-SSP-2021S
Adult prevention plan: influenza, pneumococcal, and recombinant zoster vaccines; hepatitis C, hepatitis B, and HIV screening; colonoscopy for colorectal cancer screening; eye examination; PSA discussion at 55completedGL-PREV-2026, GL-USPSTF-AB, GL-CDC-ADULT-2026, GL-USPSTF-CRC-2021S

Goals

GoalTargetStatusOutcomeProvenance
Cause of the spells established and explained to him by the neurology visit2026-08-18completedFocal epilepsy with a structural vascular cause, from a chronic left temporal cortical infarct; syncope and transient ischemic attack judged unlikelyS
No seizures on levetiracetam through the ten-week review2026-10-27completedNo seizure or spell since levetiracetam was started ten weeks agoS
Office blood pressure below 130/80 mmHg2026-10-27completed124/76 mmHg on lisinopril 10 mg and amlodipine 5 mgS
LDL cholesterol below 70 mg/dL on a high-intensity statin2026-10-27completedLDL 68 mg/dL after ten weeks of atorvastatin 80 mgS
No driving, swimming alone, or riding alone while the seizure-free period is counted, with a written seizure action plan for his staff2026-10-27activeNot driving; a driver and a riding companion arranged; seizure action plan given to his staffS

Functional Status

Mental Status